Cargando…
Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use
This cross-sectional study examines adverse drug events reported by sex in the US Food and Drug Administration (FDA) database after adjusting for drug use by males and females.
Autores principales: | Rushovich, Tamara, Gompers, Annika, Lockhart, Jeffrey W., Omidiran, Ife, Worthington, Steven, Richardson, Sarah S., Lee, Katharine M. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442708/ https://www.ncbi.nlm.nih.gov/pubmed/37603336 http://dx.doi.org/10.1001/jamanetworkopen.2023.29074 |
Ejemplares similares
-
How Cumulative Statistics Can Mislead: The Temporal Dynamism of Sex Disparities in COVID-19 Mortality in New York State
por: Danielsen, Ann Caroline, et al.
Publicado: (2022) -
Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation
por: Danielsen, Ann Caroline, et al.
Publicado: (2022) -
Are COVID-19 Case Fatality Rates a Reliable Measure of Sex Disparities?
por: Gompers, Annika, et al.
Publicado: (2022) -
Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016) -
Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)